Literature DB >> 26985633

cMyc-p53 feedback mechanism regulates the dynamics of T lymphocytes in the immune response.

Harsha S Madapura1,2, Daniel Salamon1, Klas G Wiman2, Sonia Lain1, Eva Klein1, Noémi Nagy1.   

Abstract

Activation and proliferation of T cells are tightly regulated during the immune response. We show here that kinetics of proliferation of PHA activated T cells follows the expression of cMyc. Expression of p53 is also elevated and remains high several days after activation. To investigate the role of p53 in activated T cells, its expression was further elevated with nultin-3 treatment, a small molecule that dissociates the E3 ubiquitin protein ligase MDM2 from p53. Concomitantly, cMyc expression and proliferation decreased. At the other end of the cMyc-p53 axis, inhibition of cMyc with 10058-F4 led to down regulation of p53, likely through the lower level of cMyc induced p14ARF, which is also known to dissociate the p53-MDM2 complex. Both compounds induced cell cycle arrest and apoptosis. We conclude that the feedback regulation between cMyc and p53 is important for the T cell homeostasis. We also show that the two compounds modulating p53 and cMyc levels inhibited proliferation without abolishing the cytotoxic function, thus demonstrating the dichotomy between proliferation and cytotoxicity in activated T cells.

Entities:  

Keywords:  10058-F4; T cells; apoptosis; cMyc; nutlin-3; p53

Mesh:

Substances:

Year:  2016        PMID: 26985633      PMCID: PMC4889243          DOI: 10.1080/15384101.2016.1160975

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  51 in total

1.  A gamma-secretase inhibitor blocks Notch signaling in vivo and causes a severe neurogenic phenotype in zebrafish.

Authors:  Andrea Geling; Harald Steiner; Michael Willem; Laure Bally-Cuif; Christian Haass
Journal:  EMBO Rep       Date:  2002-07       Impact factor: 8.807

Review 2.  Blinded by the Light: The Growing Complexity of p53.

Authors:  Karen H Vousden; Carol Prives
Journal:  Cell       Date:  2009-05-01       Impact factor: 41.582

Review 3.  c-Myc target genes involved in cell growth, apoptosis, and metabolism.

Authors:  C V Dang
Journal:  Mol Cell Biol       Date:  1999-01       Impact factor: 4.272

4.  Increased generation of CD8+ T cell clones in p53 mutant mice.

Authors:  X Zhou; S Wong; J Walter; T Jacks; H N Eisen
Journal:  J Immunol       Date:  1999-04-01       Impact factor: 5.422

5.  p53 contributes to T cell homeostasis through the induction of pro-apoptotic SAP.

Authors:  Harsha S Madapura; Daniel Salamon; Klas G Wiman; Sonia Lain; George Klein; Eva Klein; Noémi Nagy
Journal:  Cell Cycle       Date:  2012-11-19       Impact factor: 4.534

6.  T cell exit from quiescence and differentiation into Th2 cells depend on Raptor-mTORC1-mediated metabolic reprogramming.

Authors:  Kai Yang; Sharad Shrestha; Hu Zeng; Peer W F Karmaus; Geoffrey Neale; Peter Vogel; David A Guertin; Richard F Lamb; Hongbo Chi
Journal:  Immunity       Date:  2013-12-05       Impact factor: 31.745

Review 7.  Regulation and function of mTOR signalling in T cell fate decisions.

Authors:  Hongbo Chi
Journal:  Nat Rev Immunol       Date:  2012-04-20       Impact factor: 53.106

8.  p53-Dependent transcriptional repression of c-myc is required for G1 cell cycle arrest.

Authors:  Jenny S L Ho; Weili Ma; Daniel Y L Mao; Samuel Benchimol
Journal:  Mol Cell Biol       Date:  2005-09       Impact factor: 4.272

9.  Conditional expression and oncogenicity of c-myc linked to a CD2 gene dominant control region.

Authors:  M Stewart; E Cameron; M Campbell; R McFarlane; S Toth; K Lang; D Onions; J C Neil
Journal:  Int J Cancer       Date:  1993-04-01       Impact factor: 7.396

10.  Translocation of the c-myc gene into the immunoglobulin heavy chain locus in human Burkitt lymphoma and murine plasmacytoma cells.

Authors:  R Taub; I Kirsch; C Morton; G Lenoir; D Swan; S Tronick; S Aaronson; P Leder
Journal:  Proc Natl Acad Sci U S A       Date:  1982-12       Impact factor: 11.205

View more
  5 in total

1.  The Expression of P53, MDM2, c-myc, and P14ARF Genes in Newly Diagnosed Acute Lymphoblastic Leukemia Patients.

Authors:  Mehdi Allahbakhshian Farsani; Mohammad Rafiee; Hamideh Aghaee Nezhad; Sina Salari; Arshia Gharehbaghian; Mohammad Hossein Mohammadi
Journal:  Indian J Hematol Blood Transfus       Date:  2019-10-16       Impact factor: 0.900

Review 2.  Immunosuppressive circuits in tumor microenvironment and their influence on cancer treatment efficacy.

Authors:  Alessandra Tuccitto; Eriomina Shahaj; Elisabetta Vergani; Simona Ferro; Veronica Huber; Monica Rodolfo; Chiara Castelli; Licia Rivoltini; Viviana Vallacchi
Journal:  Virchows Arch       Date:  2018-10-29       Impact factor: 4.064

3.  Inhibition of p53 inhibitors: progress, challenges and perspectives.

Authors:  Gema Sanz; Madhurendra Singh; Sylvain Peuget; Galina Selivanova
Journal:  J Mol Cell Biol       Date:  2019-07-19       Impact factor: 6.216

4.  VPS33B interacts with NESG1 to modulate EGFR/PI3K/AKT/c-Myc/P53/miR-133a-3p signaling and induce 5-fluorouracil sensitivity in nasopharyngeal carcinoma.

Authors:  Zixi Liang; Zhen Liu; Chao Cheng; Hao Wang; Xiaojie Deng; Jiahao Liu; Chen Liu; Yonghao Li; Weiyi Fang
Journal:  Cell Death Dis       Date:  2019-04-03       Impact factor: 8.469

Review 5.  Oncogenes in immune cells as potential therapeutic targets.

Authors:  Gulnur K Zakiryanova; Sarah Wheeler; Michael R Shurin
Journal:  Immunotargets Ther       Date:  2018-04-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.